1-10 of 10
Prof. Uttam Kumar Nath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment

Free
Hanny Al-Samkari, Adam Cuker, Francesco Zaja, Marc Michel, Waleed Ghanima, Thomas Stauch, Lei Zhang, Ming Hou, Thomas Zander, Azizan Sharif, Jing Sun, Prof. Uttam Kumar Nath, Roger Schutgens, Elena Rossi, Lien Deleu, Libor Červinek, Jae-Ho Yoon, Hung Chang, Theera Ruchutrakool, Masaki Iino, Tatsunori Goto, Patrick Urban, Justyna Fronczek, Matthew Foster, Marine Weill, Nicola Cooper
Journal: Blood
Blood (2025) 146 (Supplement 2): LBA-2.
https://doi.org/10.1182/blood-2025-LBA-2
Published: 2025
Journal Articles

The novel allosteric NEK7 inhibitor ofirnoflast (HT-6184) demonstrates robust and sustained hematologic response in subjects with IPSS-R very low, low or intermediate risk myelodysplastic syndrome (MDS) and symptomatic anemia

Free
Varun Bafna, Sandip Shah, Arijit Nag, Prof. Uttam Kumar Nath, Chandran Nair, Ramesh Uppada, Devan Bursey, Andrea Groen, Victoria Allgood, Alan List, Stephen Anthony, David Bearss
Journal: Blood
Blood (2025) 146 (Supplement 1): 5622.
https://doi.org/10.1182/blood-2025-5622
Published: 2025
Journal Articles

Evaluation of response assessment in chronic lymphocytic leukaemia using measurable residual disease by flow cytometry: Prospective observational study.

Free
Karthik Jayalingappa, Bhawana Adhikari, Prisla Dalton, Bivant Shah, Kavya Ronanki, Paras Satadeve, Adamya Gupta, Reshma Benson, Arjun Kachhwaha, Shalini Singh, Manisha Naithani, Neha Singh, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2025) 146 (Supplement 1): 7438.
https://doi.org/10.1182/blood-2025-7438
Published: 2025
Journal Articles

Predictive significance of early bone marrow MRD response assessment in Acute Myeloid Leukemia patients treated with venetoclax plus decitabine induction therapy: Real-world data from India

Free
Arjun Kachhwaha, Mmcmedicine Benson, Paras Satadeve, Adamya Gupta, Bivant Shah, Prisla Dalton, Kavya Ronanki, Karthik Kumar, Sashi Singh, Jhasaketan Nayak, Nikhil Nagpal, Neha Singh, Harish Chandra, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2025) 146 (Supplement 1): 7043.
https://doi.org/10.1182/blood-2025-7043
Published: 2025
Journal Articles

Real-world impact of high-risk cytogenetics and revised ISS (R2 ISS) on response and survival in multiple myeloma patients treated with various induction regimens: A single-center study from India.

Free
Bibhant Shah, Kavya Ronanki, Prisla Dalton, Arjun Kachhwaha, Reshma Benson, Nikhil Nagpal, Paras Satadeve, Adamya Gupta, Karthik Jayalingappa, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2025) 146 (Supplement 1): 8149.
https://doi.org/10.1182/blood-2025-8149
Published: 2025
Journal Articles

Long-term rusfertide treatment in polycythemia vera: Initial results from the phase 2 THRIVE extension study

Free
Naveen Pemmaraju, Andrew Kuykendall, Ellen Ritchie, Jason Gotlib, Jeanne Palmer, Aaron Gerds, David Oubre, Prof. Uttam Kumar Nath, Gregory Vosganian, Suneel Gupta, Pedro Oyuela, Sarita Khanna, Arturo Molina, Marina Kremyanskaya
Journal: Blood
Blood (2025) 146 (Supplement 1): 3810.
https://doi.org/10.1182/blood-2025-3810
Published: 2025
Journal Articles

Dynamic changes in myeloid derived suppressor cells subsets in pediatric B cell acute lymphoblastic leukemia : Correlation with measurable residual disease status.

Free
Prisla Dalton, Kavya Ronanki, Bivant Shah, Nikhil Nagpal, Mmcmedicine Benson, Arjun Kachhwaha, Adamya Gupta, Paras Satadeve, Neha Singh, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2025) 146 (Supplement 1): 1598.
https://doi.org/10.1182/blood-2025-1598
Published: 2025
Journal Articles

Comparison of consecutive versus alternate day schedules of high-dose cytarabine consolidation chemotherapy in Acute Myeloid Leukemia: Single-center randomized controlled trial from India

Free
Kavya Ronanki, Bibhant Shah, Prisla Dalton, Adamya Gupta, Paras Satadeve, Reshma Benson, Arjun Kachhwaha, Nikhil Nagpal, Amit Sehrawat, Karthik Kumar, Karthik Jayalingappa, Anusha Mritunjayswamy, Mayank Kapoor, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2025) 146 (Supplement 1): 1687.
https://doi.org/10.1182/blood-2025-1687
Published: 2025
Journal Articles

Measurable Residual Disease Results & Survival with Augmented Early Intensification Therapy in Intermediate-Risk & High-Risk Group Pediatric Acute Lymphoblastic Leukemia Patients Treated with ALL IC-BFM 2009 Protocol: A Single-Center Study from India

Free
Prof. Uttam Kumar Nath, Karthik Kumar, Adamya Gupta, Reshma Benson, DR Arjun Kachhwaha
Journal: Blood
Blood (2023) 142 (Supplement 1): 2881.
https://doi.org/10.1182/blood-2023-188377
Published: 2023
Journal Articles

Balancing the Bleeding Risk & Treatment Related Complications in Immune Thrombocytopenia - an Unmet Need: Real-World Data from India

Free
Debranjani Chattopadhyay, Anamika Bakliwal, Sudeep Vaniyath, Rituparna Chetia, Gaurav Dhingra, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2022) 140 (Supplement 1): 11257–11258.
https://doi.org/10.1182/blood-2022-171185
Published: 2022